ASSIST PUBLIQUE HOPITAUX DE PARIS AP HP has a total of 24 patent applications. It decreased the IP activity by 41.0%. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and medical technology are ANGIOTECH INT AG, FALUS GEORGE D and HANSSON HANS ARNE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | France | 4 | |
#5 | United States | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Diagnosis and surgery | |
#5 | Operating tables |
# | Name | Total Patents |
---|---|---|
#1 | Frank Michael | 11 |
#2 | Renault Nisa | 5 |
#3 | Menasche Philippe | 5 |
#4 | Benachi Alexandra | 4 |
#5 | Robel Laurence | 4 |
#6 | Jeunemaitre Xavier | 4 |
#7 | Pidial Laetitia | 4 |
#8 | De Lonlay Pascale | 4 |
#9 | Bellamy Valerie | 3 |
#10 | Ceballos-Picot Irene | 2 |
Publication | Filing date | Title |
---|---|---|
FR3095121A1 | Medical device such as a lumbar puncture chair | |
EP3501514A1 | Use of celiprolol for treating vascular ehlers-danlos syndrome in women during pregnancy and peripartum period | |
EP3501515A1 | Method of providing celiprolol therapy to a patient | |
EP3501513A1 | Use of celiprolol for treating kyphoscoliotic ehlers-danlos syndrome | |
EP3509652A1 | Biomaterial for therapeutic use | |
CA3033446A1 | Use of an inhibitor of the de novo synthesis of purines, in the treatment of adenylosuccinate lyase deficiency | |
FR3052048A1 | ENDOSCOPIC CAP WITH REINFORCED WALL |